Relative Strength Chart Vanda Pharmaceuticals Inc.
Stocks
VNDA
US9216591084
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.870 USD | -3.77% |
|
-2.65% | -33.45% |
| 05-07 | Vanda Pharmaceuticals Inc., Q1 2026 Earnings Call, May 06, 2026 | |
| 05-06 | Vanda Pharmaceuticals Inc. Raises Revenue Guidance for the Full-Year 2026 | CI |
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| VANDA PHARMACEUTICALS INC. | Bio Therapeutic Drugs | -3.77% | -2.65% | -33.45% | +30.16% | -69.40% | 353M |  |  | |
- Stock Market
- Stocks
- VNDA Stock
- Charts Vanda Pharmaceuticals Inc.
- Relative Strength Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition